VNS Therapy™ for Epilepsy’s Post

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Participate in our Haemochromatosis activities to gain insights into common causes of under-diagnosis and misdiagnosis, induction and maintenance venesection, patient education and self-management, among other crucial aspects. https://bit.ly/3kzDkXh #cpd #CME #meded #gp

More than 80% of hospitalized patients receive IV fluids.[1] But did you know that 1 in 5 patients may suffer complications or morbidity due to inappropriate administration of IV fluids?[1] If you are interested in finding out more about our Baxter Portfolio or the NEW Multidisciplinary  Expert Panel Report on Fluid Stewardship: Perspectives and Practice[2], please contact us: https://lnkd.in/dzqBbTYp 1.National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. NICE Clinical guideline 174, 2013. 2.Manu L. N. G. Malbrain, Pietro Caironi, Robert G. Hahn, Juan V. Llau, Marcia McDougall, Luís Patrão, Emily Ridley and Alan Timmins. Annals of Intensive Care 13, 89 (2023). https://lnkd.in/dbCSF9Ez #IFAD2023, #ICU

"🚨 Medication Alert: Metronidazole + Mebendazole Interaction 🚨 In my latest carousel, I delve into the potential risk of combining these medications, unveiling the rare but serious Steven Johnson Syndrome (SJS). Discover the mechanism, safer alternatives like Albendazole (Zentel), and empower your patients with essential education. Let's prioritize patient safety together! 💊👩⚕️ #PharmacyInsights #DrugSafety #PatientCare #HealthEducation"

Diagnosing wound infections accurately is crucial for effective treatment. Methods include wound swabs and cultures, imaging studies, clinical evaluation, patient history, and point-of-care tests. These diagnostic tools help identify the presence and severity of infections, ensuring timely and appropriate care. Learn more here: https://lnkd.in/eWd5mrQE #woundcare #infectioncontrol #medicaldiagnostics #healthcare #patientcare #woundmanagement #thewoundpros #medicaltips #clinicalevaluation #healthandwellness #nursingcare #woundhealing

Join us tonight for the VECCS x VIN Webinar with Marcia Fletcher! Learn about anesthetizing compromised patients, preparation, stabilization methods, and more. Check your member emails for details!

Amplity Health ‘s dedication and expertise in #rarediseases is so inspiring in how we help advance patient care and outcomes. Especially with our Diagnostic Liaisons like Sarah. For our #RareDisease Patient Diagnostic Liaisons, this often means uncovering individuals with specific orphan conditions when clinical trials, other real-world research, and support programs are available. As Sarah Feinsmith, MSN, APRN, RN, CNS, explains, we leverage our deep rare disease expertise to “bridge the gap between the healthcare providers, patients, and our clients to help advance patient care, improve patient diagnosis, and ultimately improve patient outcomes, wellbeing, and quality of life.” #rarediseaseday2024 #rarediseases #partners #patientoutcomes #strategicpartnerships #bridgethegap

Now Available! IgNS Immunoglobulin Therapy Standards of Practice, 3.1! 🌟 Dive into new guidelines, major practice updates, and updated competency requirements. Safeguard your practice and elevate patient care. Purchase now! https://lnkd.in/eVS2hx8v 💉🩺 #IgNS #IgNSStandards #IgNSUpdates